Gene therapy induces sustained and normalised levels of factor IX in haemophilia B

Gene therapy use in a phase 2 trial for patients with haemophilia B induced sustained increases in factor IX levels in virtually all patients.
https://www.google.com/url?rct=j&sa=t&url=https://hospitalhealthcare.com/latest-issue/haematology-and-oncology/gene-therapy-induces-sustained-and-normalised-levels-of-factor-ix-in-haemophilia-b/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw0EeTgdo_va14FR5sy5X-72